Claudio Vernieri
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 46
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 9
- HER2/EGFR in Cancer Research 8
-
- Breast Cancer Treatment Studies 11
- Cancer, Lipids, and Metabolism 8
- Co-authors
- Filippo de Braud (49 shared papers)Valter D. Longo (7 shared papers)Riccardo Lobefaro (16 shared papers)Marco Foiani (5 shared papers)Francesca Ligorio (23 shared papers)Andrea Ciliberto (4 shared papers)Giulia Bianchi (21 shared papers)Fabrizio Villa (1 shared paper)
- Journals
- Annals of Oncology (12 papers)Journal of Clinical Oncology (9 papers)Cancers (6 papers)ESMO Open (5 papers)Therapeutic Advances in Medical Oncology (4 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Claudio Vernieri
86 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 88
- Oncology 698
- Cancer Research 343
- Cell Biology 199
- Molecular Biology 698
- Physiology 190
Countries citing papers authored by Claudio Vernieri
This map shows the geographic impact of Claudio Vernieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Vernieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Vernieri more than expected).
Fields of papers citing papers by Claudio Vernieri
This network shows the impact of papers produced by Claudio Vernieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Vernieri. The network helps show where Claudio Vernieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Vernieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 164 | |
| 2 | 2019 | 160 | |
| 3 | 2011 | 156 | |
| 4 | 2016 | 137 | |
| 5 | 2020 | 114 | |
| 6 | 2021 | 103 | |
| 7 | 2021 | 84 | |
| 8 | 2018 | 81 | |
| 9 | 2020 | 70 | |
| 10 | 2022 | 53 | |
| 11 | 2020 | 47 | |
| 12 | 2018 | 46 | |
| 13 | 2018 | 42 | |
| 14 | 2021 | 34 | |
| 15 | 2016 | 34 | |
| 16 | 2021 | 32 | |
| 17 | 2020 | 32 | |
| 18 | 2018 | 31 | |
| 19 | 2019 | 25 | |
| 20 | 2020 | 23 |
About Claudio Vernieri
Claudio Vernieri is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 92 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (14 papers), Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Metabolism, Diabetes, and Cancer (9 papers), Lung Cancer Research Studies (9 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Oncology (698 citations), Cancer Research (343 citations), Cell Biology (199 citations), Molecular Biology (698 citations) and Physiology (190 citations). Claudio Vernieri has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Filippo de Braud, Valter D. Longo, Riccardo Lobefaro, Marco Foiani, Francesca Ligorio, Andrea Ciliberto, Giulia Bianchi, Fabrizio Villa, Stefano Santaguida and Giuseppe Capri. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancers, ESMO Open and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.